These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Recombinant factor VIIa treatment for life-threatening haemoptysis.
    Author: Yildirim H, Ucgun I, Yalcin AU, Gulbaş Z, Sahin G, Acikalin MF, Metintas M, Ak G.
    Journal: Respirology; 2006 Sep; 11(5):652-4. PubMed ID: 16916342.
    Abstract:
    Diffuse alveolar haemorrhage is a severe clinical disorder that may be life-threatening. The early diagnosis of diffuse alveolar haemorrhage and prompt intervention is crucial. Recombinant factor VIIa has been used extensively for the treatment of haemophilia A and B patients. More recently, recombinant factor VIIa has been used successfully for the treatment of bleeding in patients without pre-existing coagulopathy. We describe the successful use of recombinant factor VIIa in a patient with diffuse alveolar haemorrhage secondary to pulmonary-renal syndrome.
    [Abstract] [Full Text] [Related] [New Search]